Skip to content
10-Q

Quarterly Report

Targeted Medical Pharma, Inc.

0001493152-14-002549

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 13, 2014 26.55M sh
Stockholders Equity Q2 2014 · Jun 30, 2014 −$7.93M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$7.02M
Current Liabilities Q2 2014 · Jun 30, 2014 $11.76M
Current Liabilities Q2 2014 · Dec 31, 2013 $11.26M
Total Liabilities Q2 2014 · Jun 30, 2014 $11.76M
Total Liabilities Q2 2014 · Dec 31, 2013 $12.02M
Current Assets Q2 2014 · Jun 30, 2014 $1.66M
Current Assets Q2 2014 · Dec 31, 2013 $2.63M
Stock Issued Q2 2014 · Mar 31, 2014 281.67K sh
Total Assets Q2 2014 · Dec 31, 2013 $5M
Total Assets Q2 2014 · Jun 30, 2013 $5.07M
Capex Q2 2014 · Jun 30, 2013 $23.48K
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$290.13K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $25.95K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $326.6K
Sga Expense Q2 2014 · Jun 30, 2013 $2.97M
Sga Expense Q2 2014 · Jun 30, 2013 $5.35M
Rd Expense Q2 2014 · Jun 30, 2013 $34.03K
Rd Expense Q2 2014 · Jun 30, 2013 $66.11K
Net Income Q2 2014 · Jun 30, 2013 −$7.84M
Net Income Q2 2014 · Jun 30, 2013 −$8.11M
Operating Income Q2 2014 · Jun 30, 2013 −$1.82M
Operating Income Q2 2014 · Jun 30, 2013 −$2.33M
Gross Profit Q2 2014 · Jun 30, 2013 $1.18M
Gross Profit Q2 2014 · Jun 30, 2013 $3.09M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $735.47K
Cost Of Revenue Q2 2014 · Jun 30, 2013 $1.63M
Revenue Q2 2014 · Jun 30, 2013 $1.92M
Revenue Q2 2014 · Jun 30, 2013 $4.73M